Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

S A Spector

Showing results (141-150 of 196) with videos related to

Pageof 20
Sort By:
The Journal of Protozoology|November 1, 1991
The impact of concomitant viral pathogens on the course of Pneumocystis carinii pneumoniaS A Bozzette, J Arcia, A E Bartok, et al.
Journal of Clinical Microbiology|April 3, 2001
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasmaA M Caliendo, R Schuurman, B Yen-Lieberman, et al.
The Pediatric Infectious Disease Journal|June 1, 1997
Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials GroupS A Spector, S Blanchard, D W Wara, et al.
Journal of Clinical Microbiology|December 1, 1994
Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases)J L Lathey, S A Fiscus, S Rasheed, et al.
Journal of Virology|March 1, 1994
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapyD D Richman, D Havlir, J Corbeil, et al.
Transplantation|December 15, 1994
Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipientsS A Plotkin, R Higgins, J B Kurtz, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I studyT C Meng, M A Fischl, S H Cheeseman, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Peripheral nerve function in persons with asymptomatic or minimally symptomatic HIV disease: absence of zidovudine neurotoxicityS A Bozzette, J Santangelo, D Villasana, et al.
The Journal of Infectious Diseases|March 1, 1995
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infectionD Havlir, S H Cheeseman, M McLaughlin, et al.
Pageof 20

Showing results (141-150 of 196) with videos related to

Sort By:
Pageof 20
The Journal of Protozoology|November 1, 1991
The impact of concomitant viral pathogens on the course of Pneumocystis carinii pneumoniaS A Bozzette, J Arcia, A E Bartok, et al.
Journal of Clinical Microbiology|April 3, 2001
Comparison of quantitative and qualitative PCR assays for cytomegalovirus DNA in plasmaA M Caliendo, R Schuurman, B Yen-Lieberman, et al.
The Pediatric Infectious Disease Journal|June 1, 1997
Comparative trial of two dosages of zalcitabine in zidovudine-experienced children with advanced human immunodeficiency virus disease. Pediatric AIDS Clinical Trials GroupS A Spector, S Blanchard, D W Wara, et al.
Journal of Clinical Microbiology|December 1, 1994
Optimization of quantitative culture assay for human immunodeficiency virus from plasma. Plasma Viremia Group Laboratories of the AIDS Clinical Trials Group (National Institute of Allergy and Infectious Diseases)J L Lathey, S A Fiscus, S Rasheed, et al.
Journal of Virology|March 1, 1994
Nevirapine resistance mutations of human immunodeficiency virus type 1 selected during therapyD D Richman, D Havlir, J Corbeil, et al.
Transplantation|December 15, 1994
Multicenter trial of Towne strain attenuated virus vaccine in seronegative renal transplant recipientsS A Plotkin, R Higgins, J B Kurtz, et al.
The Journal of Infectious Diseases|November 9, 2000
Patterns of plasma human immunodeficiency virus type 1 RNA response to highly active antiretroviral therapy in infected childrenS A Spector, K Hsia, F H Yong, et al.
Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology : Official Publication of the International Retrovirology Association|February 1, 1995
Combination therapy with recombinant human soluble CD4-immunoglobulin G and zidovudine in patients with HIV infection: a phase I studyT C Meng, M A Fischl, S H Cheeseman, et al.
Journal of Acquired Immune Deficiency Syndromes|January 1, 1991
Peripheral nerve function in persons with asymptomatic or minimally symptomatic HIV disease: absence of zidovudine neurotoxicityS A Bozzette, J Santangelo, D Villasana, et al.
The Journal of Infectious Diseases|March 1, 1995
High-dose nevirapine: safety, pharmacokinetics, and antiviral effect in patients with human immunodeficiency virus infectionD Havlir, S H Cheeseman, M McLaughlin, et al.
Pageof 20